2:04

Liliana Pang explains how manufacturers test whether preservatives in foods, cosmetics, and medications actually work. Products get challenged with five standard microbes, and to pass, bacterial counts must drop by 1 to 3 log while fungal counts stay flat.

Questions this video answers

Liliana Pang, Research Associate at Emeryville Pharmaceutical Services.

Aspergillus brasiliensis; Candida albicans; Escherichia coli; Pseudomonas aeruginosa; Staphylococcus aureus.

Fungal strain counts must not increase; bacterial strains must decrease by 1 to 3 log.

USP 51; EP 5.1.3; JP 19.

Phone: 510-899-8828 (free one-hour consultation).

Chapters

More from Dr.

youtube.com

Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health

11mo ago
youtube.com

Robert Lustig, MD: Everything You Know About Obesity Is Wrong

11mo ago
youtube.com

What is the latest on Ozempic and Ozempic like drugs #ozempic #glp1

11mo ago
youtube.com

Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It

11mo ago
youtu.be

Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.

11mo ago
youtube.com

The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig

11mo ago
youtube.com

Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet

1y ago
youtube.com

Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome

1y ago
youtube.com

Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose

1y ago
youtube.com

Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance

1y ago
youtube.com

Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet

1y ago
See all content